Everything below concerns lyophilisation. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-09-28. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic cyclic heptapeptide | Analog of alpha-MSH with an internal lactam bridge |
| Molecular weight | Approximately 1024 daltons | Free base value; salt forms differ |
| Appearance | White to off-white powder | Usually supplied as a lyophilized solid |
| Solubility | Freely soluble in water | Poorly soluble in nonpolar solvents |
| Typical storage | −20 °C, dry, protected from light | Repeated freeze-thaw cycles degrade peptides |
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
The compound was developed in the late 1980s and 1990s by academic researchers investigating photoprotection. The rationale held that stimulating melanin production might reduce ultraviolet damage to skin and lower skin cancer risk. Early work examined receptor binding, pigment response, and short-term tolerability in small studies. That program did not produce an approved drug, and formal development stalled after early-phase trials. Whether induced pigmentation confers meaningful photoprotection remains an open question.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
== Formulation types == The drug form varies by its way to be administered into the body called route of administration including oral, sublingual, transdermal and inhalation delivery It can be delivered as capsules, tablets, granules, pills etc.
== Honors and awards == 1971 ACS Award in Chemical Instrumentation 1981 ACS Award in Analytical Chemistry 1984 William H. Nichols Medal 1985 Oesper Award 1985 J. J. Thomson Gold Medal by International Mass Spectrometry Society 1987 Pittsburgh Analytical Chemistry Award 1989 Field and Franklin Award for Mass Spectrometry 1989 University of Naples Gold Medal 1992 Robert Boyle Gold Medal by the Royal Society of Chemistry 1996 Chemical Pioneer Award from the American Institute of Chemists 1997 Bijvoet Medal of the Bijvoet Center for Biomolecular Research. 1999 J. Heyrovsky Medal by the Czech Academy of Sciences 2000 G. Natta Gold Medal by Italian Chemical Society 2001 Torbern Bergman Medal by the Swedish Chemical Society 2003 John B. Fenn Distinguished Contribution in Mass Spectrometry by the American Society for Mass Spectrometry (ASMS) 2004 Lavoisier Medal by the French Chemical Society 2006 Pehr Edman Award by the International Association for Protein Structure 2015 Nakanishi Prize from the American Chemical Society 2019 American Chemical Society designated a National Historic Chemical Landmark in Midland, MI for the demonstration of the first operating GC-MS by Fred McLafferty and Roland Gohlke.
=== Pharmacokinetics === Risperidone undergoes hepatic metabolism and renal excretion. Lower doses are recommended for patients with severe liver and kidney disease. The active metabolite of risperidone, paliperidone, is also used as an antipsychotic.
It has also been stated however that suicidal ideation was reported in 0% to 1.6% of people taking 10 to 20 mg and 3.4% to 8.2% taking 40 to 80 mg relative to 0% to 0.3% with placebo. Suicidal ideation with suvorexant is considered to be mild. In any case, caution is warranted in use of suvorexant in people with depression, and people with worsening depression or suicidal thoughts should be promptly evaluated. Besides the clinical trial data, a case report of rapidly worsened depression and onset of suicidal ideation with suvorexant has been published. The next-day effects of suvorexant have been studied. Besides the side effect of daytime somnolence, suvorexant may dose-dependently reduce alertness and motor coordination and impair driving ability. It may also increase the risk of falling asleep while driving. Driving ability was found to be impaired at doses of 20 and 40 mg in clinical studies. Driving impairment may also occur with lower doses of suvorexant due to variations in individual sensitivity to the medication. In three of four studies, 30 mg suvorexant had no influence on next-day memory or balance, whereas in the remaining study, there was a decrease in morning word recall with 40 mg and an increase in body sway with 20 and 40 mg doses. In another study in elderly people who were awakened in the night, impaired balance was present at 1.5 hours after taking 30 mg suvorexant whereas memory was unaffected.
Sources: en.wikipedia.org
Muscle weakness can also be classified as either "proximal" or "distal" based on the location of the muscles that it affects. Proximal muscle weakness affects muscles closest to the body's midline, while distal muscle weakness affects muscles further out on the limbs. Proximal muscle weakness can be seen in Cushing's syndrome and hyperthyroidism.
According to a survey investigation by the sociologist Jenny Hansson, Swedish national parliamentarians have an average workweek of 66 hours, including side responsibilities. Hansson's investigation further reports that the average Swedish national parliamentarian sleeps 6.5 hours per night.
Thin reticular fibers (reticulin) of reticular connective tissue form a supporting meshwork inside the node. These reticular cells also form a conduit network within the lymph node that functions as a molecular sieve, to prevent pathogens that enter the lymph node through afferent vessels re-enter the blood stream. The lymph node capsule is composed of dense irregular connective tissue with some plain collagenous fibers, and a number of membranous processes or trabeculae extend from its internal surface. The trabeculae pass inward, radiating toward the center of the node, for about one-third or one-fourth of the space between the circumference and the center of the node. In some animals they are sufficiently well-marked to divide the peripheral or cortical portion of the node into a number of compartments (nodules), but in humans this arrangement is not obvious. The larger trabeculae springing from the capsule break up into finer bands, and these interlace to form a mesh-work in the central or medullary portion of the node. These trabecular spaces formed by the interlacing trabeculae contain the proper lymph node substance or lymphoid tissue. The node pulp does not, however, completely fill the spaces, but leaves between its outer margin and the enclosing trabeculae a channel or space of uniform width throughout. This is termed the subcapsular sinus (lymph path or lymph sinus). Running across it are a number of finer trabeculae of reticular fibers, mostly covered by ramifying cells.
Marsha Linehan's biosocial developmental theory posits that BPD arises from the interaction between a child's inherent emotional vulnerability and an invalidating environment—an environment characterized by the neglect, ridicule, dismissal, or discouragement of a child's emotions and needs. Due to it drawing on attachment theory, which centers Western nuclear family norms, the diagnosis of BPD has been critiqued by Indigenous and decolonial scholars for possibly pathologizing Indigenous and collectivist cultural forms of caregiving.
== Ligands == PD-1 has two ligands, PD-L1 and PD-L2, which are members of the B7 family. PD-L1 protein is upregulated on macrophages and dendritic cells (DC) in response to LPS and GM-CSF treatment, and on T cells and B cells upon TCR and B cell receptor signaling, whereas in resting mice, PD-L1 mRNA can be detected in the heart, lung, thymus, spleen, and kidney. PD-L1 is expressed on almost all murine tumor cell lines, including PA1 myeloma, P815 mastocytoma, and B16 melanoma upon treatment with IFN-γ. PD-L2 expression is more restricted and is expressed mainly by DCs and a few tumor lines.
Sources: en.wikipedia.org
Graphite oxide (GO), formerly called graphitic oxide or graphitic acid, is a compound of carbon, oxygen, and hydrogen in variable ratios, obtained by treating graphite with strong oxidizers and acids for resolving of extra metals. The maximally oxidized bulk product is a yellow solid with C:O ratio between 2.1 and 2.9, that retains the layer structure of graphite but with a much larger and irregular spacing. The bulk material spontaneously disperses in basic solutions or can be dispersed by sonication in polar solvents to yield monomolecular sheets, known as graphene oxide by analogy to graphene, the single-layer form of graphite. Graphene oxide sheets have been used to prepare strong paper-like materials, membranes, thin films, and composite materials. Initially, graphene oxide attracted substantial interest as a possible intermediate for the manufacture of graphene. The graphene obtained by reduction of graphene oxide still has many chemical and structural defects which is a problem for some applications but an advantage for some others.
A letter from James Bowler, the Permanent Secretary to the Treasury, subsequently emerges in which he says the Conservative allegations "should not be presented as having been produced by the civil service". Faiza Shaheen is deselected as Labour candidate for Chingford and Woodford Green and subsequently resigns from the party. Two people are arrested after a milkshake is thrown at Reform UK leader Nigel Farage as he launches his campaign in Clacton. 5 June – Alba Party leader Alex Salmond confirms he will not stand in the general election, but instead plans to stand in the 2026 Scottish Parliament election in Banff and Buchan. First Minister of Wales Vaughan Gething loses a nonbinding vote of no confidence in the Senedd with members voting 29–27 in favour of a motion put forward by the Welsh Conservatives. It follows an investigation into the activities of a leading donor to his election campaign. Gething says he will not resign following the vote. Richard Holden is selected as the Conservative candidate for Basildon and Billericay. David Duguid is prevented from standing as the Conservative candidate in Aberdeenshire North and Moray East. Instead, Douglas Ross, who had previously intended to stand down at the election, announces he will contest the constituency at a press conference the next day. 6 June – The Office for Statistics Regulation criticises Sunak for his comments about Labour tax rises, saying most people would have been unaware the figures related to a four year period.
== Characteristics == 210Po is an alpha emitter that has a half-life of 138.4 days; it decays directly to its stable daughter isotope, 206Pb. A milligram (5 curies) of 210Po emits about as many alpha particles per second as 5 grams of 226Ra, which means it is 5,000 times more radioactive than radium. A few curies (1 curie equals 37 gigabecquerels, 1 Ci = 37 GBq) of 210Po emit a blue glow which is caused by ionisation of the surrounding air. About one in 100,000 alpha emissions causes an excitation in the nucleus which then results in the emission of a gamma ray with a maximum energy of 803 keV.
Synthetic biology (SynBio) is a multidisciplinary scientific field that applies the principles of engineering to develop new biological parts, devices, and systems or to redesign existing systems found in nature. The field encompasses a broad range of methodologies from various disciplines, such as biochemistry, biotechnology, biomaterials, material science/engineering, genetic engineering, molecular biology, molecular engineering, systems biology, membrane science, biophysics, chemical and biological engineering, electrical and computer engineering, control engineering and evolutionary biology. It includes designing and constructing biological modules, biological systems, and biological machines, or re-designing existing biological systems for useful purposes. Additionally, it is the branch of science that focuses on the new abilities of engineering into existing organisms to redesign them for useful purposes. In order to produce predictable and robust systems with novel functionalities that do not already exist in nature, it is also necessary to apply the engineering paradigm of systems design to biological systems. According to the European Commission, this possibly involves a molecular assembler based on biomolecular systems such as the ribosome.
Norbert Elias; (1897-1990) sociologist especially famous for theory of civilising/decivilising processes; was deeply involved in the German Zionist movement, and acted as one of the leading intellectuals within the German-Jewish youth movement "Blau-Weiss" (Blue-White). Elias' most famous work is The Civilizing Process Samantha Ellis is an Iraqi Jewish British playwright and writer best known for her books How to be a Heroine, Chopping Onions on My Heart, and her play How to Date a Feminist. Richard Ellmann literary scholar and biographer Aaron Esterson (23 September 1923 – 15 April 1999) prolific author and psychiatrist who was one of the founders of the Philadelphia Association along with R. D. Laing, with whom he wrote Sanity, Madness, and the Family. He wrote four other scholarly texts on psychiatry and existentialism as well as countless academic papers and monographs. Hans Eysenck (4 March 1916 – 4 September 1997); author of over fifty books and numerous academic papers; of German Jewish maternal lineage; psychologist best remembered for his work on intelligence and personality, although he worked on other issues in psychology. At the time of his death, Eysenck was the most frequently cited living psychologist in the peer-reviewed scientific journal literature. Henry Ezriel (c1910-1985) was a Kleinian analyst and author who pioneered group analysis at the Tavistock Clinic; best known as the originator of one of the Malan triangles; worked alongside W. R. Bion as consultant psychiatrist to the Tavistock.
Sources: en.wikipedia.org
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.
Melanotan-1, also called afamelanotide, is a shorter linear analog with a different amino acid sequence and no lactam ring. It has been evaluated in formal clinical programs, while melanotan-2 has not. The two are distinct molecules and are not interchangeable.
No. Bremelanotide is a related but distinct cyclic peptide that reached approved status for one specific clinical indication. Melanotan-2 is a separate molecule with its own sequence and properties. Shared ancestry in the melanocortin family does not make them the same substance.
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.